Clinical Trial Update: Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 study evaluating enzalutamide plus flutamide in castration-resistant prostate cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• flutamide (flutamide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2021-05-21